Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FSBZ5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,623
Award facts
- Contract value 100% obligated
- $25,622.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,622.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award utilizes no subcontractor relationships and is funded entirely by the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was awarded on the same date with a ceiling value of $499,999,999 and completion date of December 31, 2036. The underlying IDC is part of the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply branded and generic pharmaceuticals, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. The contract structure includes a 30-month base period with three 30-month option periods, positioning DMS Pharmaceutical Group as a critical supplier for DoD military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FSBZ5?
SPE2DR26FSBZ5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FSBZ5 worth?
The government has obligated $25,623 on SPE2DR26FSBZ5.
Is contract SPE2DR26FSBZ5 an order under another contract?
Yes. SPE2DR26FSBZ5 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSBZ5 competed?
The extent of competition for SPE2DR26FSBZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award